US2005106153A1PendingUtilityA1
Combined physical and immunotherapy for cancer
Est. expiryApr 4, 2015(expired)· nominal 20-yr term from priority
C08B 37/003A61P 37/04A61K 45/06A61K 31/722A61P 35/00C07K 16/30A61K 39/0011
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immuno-modulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.
Claims
exact text as granted — not AI-modified1 . A method for treating a tumor in a human or other animal host to achieve acute tumor destruction while concomitantly stimulating a host immune response against a proliferation of residual or metastatic tumor cells, comprising:
(a) administering an immunomodulator to the host so as to potentiate or augment an immunologic response to the presence in the host of fragmented neoplastic tissue and cellular molecules; and (b) generating fragmented neoplastic tissue and cellular molecules from the tumor, thereby reducing tumor burden while effecting the stimulation of the immunologic response.
2 . The method according to claim 1 , wherein said immunomodulator stimulates the host's antitumor response by increasing the number of effector cells or producing one or more soluble mediators.
3 . The method according to claim 1 , wherein said immunodulator serves as an effector or mediator.
4 . The method according to claim 1 , wherein said immunodulator decreases host suppressor mechanisms.
5 . The method according to claim 1 , wherein said immunodulator alters tumor cells to increase their immunogenicity or otherwise makes said cells more likely to be damaged by immunologic processes.
6 . The method according to claim 1 , wherein said immunodulator improves the host's tolerance to cytotoxics or radiation therapy.
7 . The method according to claim 1 , wherein step (b) is accomplished by performing a phototherapy on the tumor.
8 . The method according to claim 7 , wherein said phototherapy comprises a thermal phototherapy.
9 . The method according to claim 7 , wherein said phototherapy comprises a nonthermal cytotoxic phototherapy.
10 . The method according to claim 1 , wherein step (b) is accomplished by inducing hyperthermia in the tumor via a means therefor.
11 . The method according to claim 10 , wherein said means comprises laser light.
12 . The method according to claim 10 , wherein said means comprises ultrasound.
13 . The method according to claim 10 , wherein said means comprises microwaves.
14 . The method according to claim 10 , wherein said means comprises radio frequency induction.
15 . The method according to claim 10 , wherein said means comprises an electric current.
16 . The method according to claim 1 , wherein step (b) is accomplished by performing cryotherapy on the tumor.
17 . The method according to claim 1 , wherein said immunomodulator is administered intratumorally.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.